Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer's Disease Management

S Dighe, S Jog, M Momin, S Sawarkar, A Omri - Pharmaceutics, 2023 - mdpi.com
Alzheimer's disease, a progressive neurodegenerative condition, is characterized by a
gradual decline in cognitive functions. Current treatment approaches primarily involve the …

Effect of Low Doses of Dexamethasone on Experimental Pulmonary Tuberculosis

JV Lara-Espinosa, MF Arce-Aceves, J Barrios-Payán… - Microorganisms, 2023 - mdpi.com
Tuberculosis (TB) is the deadliest disease caused by a bacterial agent. Glucocorticoids
(GCs) have a typical anti-inflammatory effect, but recently it has been shown that they can …

A Comprehensive Review on the Nanotechnology-based Intranasal Drug Delivery Systems for Brain Targeting

A Simhadri, MD Dommeti, J Sana - Journal of Pharma Insights and Research, 2024 - jopir.in
Intranasal drug delivery has emerged as a promising non-invasive route for targeting the
central nervous system, bypassing the blood-brain barrier and minimizing systemic side …